Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells

<div>Viability and development of apoptosis and necrosis in canine mammary gland tumor (CMT) adenocarcinoma cells caused by ZER-NLC, ZER, and NLC treatments. ZER- and ZER-NLC-treated cells showed increase in late apoptotic cells with increasing period of treatment (<i>p</i>&lt;0.0001). NLC: nanostructured lipid carrier; ZER: zerumbone; ZER-NLC: zerumbone-loaded nanostructured lipid carrier.</div>

BioMed Research International

fig9

Figure 9

Figure 9: Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells 